The most common cause of vision loss in people with diabetes, diabetic retinopathy is the leading cause of blindness among adults aged 20 to 74 1 and affects nearly 7.7 million people in the U.S. 2 ...

Treating people in the early stages of diabetes-related eye disease may help slow the progression of the condition, but a new study also suggests that it can’t help prevent vision loss in the future.

Diabetic retinopathy is the most common cause of diabetic vision loss resulting from high blood sugar that damages the retina ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies ...

February 7, 2012 — The Diabetic Retinopathy Clinical Research (DRCR) Network is a network of community- and academic-based ophthalmologists that has been conducting clinical research related to ...

Patients with type 2 diabetes who received intravitreal anti-vascular endothelial growth factor (VEGF) injections for diabetic retinopathy were more likely to develop systemic adverse events (AEs) ...

A report in the December issue of the Archives of Ophthalmology shows that injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of ...

If you have diabetes, prediabetes, or gestational diabetes (diabetes that occurs during pregnancy), keep your eye on a potential complication that can compromise eyesight. Diabetic retinopathy (DR), ...

Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids ...

Dr. Samuel Barry & Lea Rapier talk to ciLiving host, Jaclyn Friedlander about undergoning premium cataract surgery as well as diabetic eye injections Discover how Chittick Eye Care is helping patients ...

Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection 2 mg that were maintained with fewer ...

Diabetic retinopathy is an eye condition that can cause vision changes and vision loss. There are four stages of diabetic retinopathy based on the findings of a dilated eye exam. Diabetic retinopathy ...